<?xml version="1.0"?>
<case>
<name>Bayer Bioscience N.V. v Deltapine Australia Pty Ltd (No 2) [2006] FCA 1762 (15 December 2006)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2006/1762.html</AustLII>
<citphrases>
<citphrase id="cp1.0" type=citing from="[2009] FCA 1330">trade practices</citphrase>
<citphrase id="cp1.1" type=citing from="[2009] FCA 1330">interlocutory injunction</citphrase>
<citphrase id="cp1.2" type=citing from="[2009] FCA 1330">restraining from importing distributing supplying offering for sale or selling goods of a same design and appearance</citphrase>
<citphrase id="cp1.3" type=citing from="[2009] FCA 1330">passing off</citphrase>
<citphrase id="cp1.4" type=citing from="[2009] FCA 1330">breach of ss 52 and 53 of the trade practices act 1974 (cth).   evidence</citphrase>
<citphrase id="cp1.5" type=citing from="[2009] FCA 1330">hearsay expert opinion</citphrase>
<citphrase id="cp1.6" type=citing from="[2009] FCA 1330">need to comply with ss 76 and 79 of the evidence act 1995 (cth).</citphrase>
</citphrases>
<citances>
<sentence id="cs0" from="[2009] FCA 1330">As a separate matter, I should indicate that I do not accept that by reason of the operation of O 58 r 31 of the Rules of Court that the evidence sought to be introduced by the applicants on this issue (including the Falcon tests) should be rejected. The Rule would not prevent this Court from considering the Flacon tests sought to be introduced by the applicants if they otherwise complied with the requirements of the Evidence Act : see generally Bayer Bioscience NV v Deltapine Australia Pty Ltd (No.2) [2006] FCA 1762 ; (2006) 71 IPR 40 per Heerey J. </sentence>
</citances>
<legistitles>
<title id="l0">EVIDENCE ACT 1995 </title>
<title id="l1">EVIDENCE ACT 1995 - SECT 135 General discretion to exclude evidence</title>
<title id="l2">FEDERAL COURT RULES 1979 </title>
</legistitles>
</case>